EBS Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeWall Street coverage
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Valuation
- Forward P/E
- 2.08
- PEG ratio
- 0.38
- P/B
- 0.84
- P/S (TTM)
- 0.60
- EV/EBITDA
- 5.56
Profitability & growth
- ROE (TTM)
- -1.6%
- Operating margin
- 6.8%
- Revenue growth YoY
- -29.7%
- Dividend yield
- —
- Beta
- 2.33
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
50 articles · sorted by dateVia 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About Emergent Biosolutions Inc
Company profileEmergent BioSolutions Inc., a life sciences company, focuses on providing preparedness and response products and solutions for civilian and military populations that address accidental, deliberate, and naturally occurring public health threats (PHT). The company is headquartered in Gaithersburg, Maryland.
Classification
- Sector
- Healthcare
- Exchange
- NYSE
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 300 PROFESSIONAL DRIVE, GAITHERSBURG, MD
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
I'm your AI thinking companion for the markets — I can help you explore and learn, but I'm not a financial advisor. Everything here is educational. Disclaimer